# TOFACITINIB CITRATE
> **ANDA219830** · Abbreviated New Drug Application (Generic) · Sponsor: ORIENT PHARMA · Approved 2026-06-09
## Drug
- **FDA Application Number:** ANDA219830
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOFACITINIB CITRATE
- **Generic name:** TOFACITINIB
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ORIENT PHARMA
- **Manufacturer:** Orient Pharma Co., Ltd. Yunlin Plant
- **First approval:** 2026-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219830)
---
*MORVS · CC0 1.0*